2023
DOI: 10.1016/j.jddst.2023.104960
|View full text |Cite
|
Sign up to set email alerts
|

pH-responsive MTX-BSA@MnO2-Cy5.5 for NIRF/MR imaging guided chemotherapy of anaplastic thyroid carcinoma

Zhengrong Xie,
Qiushi Jia,
Shuang Wu
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 44 publications
0
1
0
Order By: Relevance
“…For instance, Xie et al used BSA-biomineralized MnO 2 as a carrier for loading the anti-tumor drug methotrexate (MTX) and fluorescent dye Cy5.5 through amide condensation, to prepare the nanodrug MTX-BSA@MnO 2 -Cy5.5 (MBMC NPs). 99 The designed MBMC NPs are for the diagnosis and treatment of anaplastic thyroid carcinoma. MBMC NPs showed good pH-responsive drug release and imaging performance.…”
Section: Biomedical Applicationsmentioning
confidence: 99%
“…For instance, Xie et al used BSA-biomineralized MnO 2 as a carrier for loading the anti-tumor drug methotrexate (MTX) and fluorescent dye Cy5.5 through amide condensation, to prepare the nanodrug MTX-BSA@MnO 2 -Cy5.5 (MBMC NPs). 99 The designed MBMC NPs are for the diagnosis and treatment of anaplastic thyroid carcinoma. MBMC NPs showed good pH-responsive drug release and imaging performance.…”
Section: Biomedical Applicationsmentioning
confidence: 99%